Joel Habener

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Salamalet Yigit22 (talk | contribs) at 17:24, 25 June 2020 (dead link). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2]

References

  1. ^ https://warrenalpert.org/prize-recipients
  2. ^ http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html
Retrieved from "https://en.wikipedia.org/w/index.php?title=Joel_Habener&oldid=964466095"